BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3283 related articles for article (PubMed ID: 6984864)

  • 1. [Effect of intra-tumoral injection of tuberculin-active protein on growth of transplantable mouse melanomas].
    Saida T
    Nihon Hifuka Gakkai Zasshi; 1982 Nov; 92(13):1389-98. PubMed ID: 6984864
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of intra-lesional injection of tuberculin-active protein on metastatic nodules of human malignant melanoma].
    Saida T
    Nihon Hifuka Gakkai Zasshi; 1982 Nov; 92(13):1399-414. PubMed ID: 6984865
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of BCG and C. parvum treatment on human melanoma xenografts.
    Garrett AJ; Reeson DE; Osborn TW; Boulger LR
    Dev Biol Stand; 1977 Apr 13-15; 38():363-8. PubMed ID: 608525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [BCG-induced production of a factor inhibiting macrophage migration and growth of melanoma B16].
    Gankovskaia LV; Pyl'nova TI; Sokolova EV; Koval'chuk LV
    Biull Eksp Biol Med; 1980 Sep; 90(9):346-8. PubMed ID: 7000202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of repeated administration of BCG vaccine combined with surgery on the growth dynamics of transplantable Guérin tumor in rats].
    Nowak HF; Jodczyk KJ; Cylwik B; Zimnoch L; Głowińska L; Duda D; Plezia E; Bernaczyk A
    Patol Pol; 1981; 32(2):161-71. PubMed ID: 7322638
    [No Abstract]   [Full Text] [Related]  

  • 6. [Unspecific, active BCG vaccination therapy in melanoma using a modified scarification procedure].
    Wolf M; Menzel W; Keller G
    Dermatol Monatsschr; 1978 Apr; 164(4):302-3. PubMed ID: 668966
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunotherapy of malignant melanomas].
    Macher E
    Haematol Blood Transfus; 1978; 21():285-91. PubMed ID: 738638
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multiple BCG-induced ulcers after subcutaneous vaccination in the framework of immunochemotherapy in malignant melanoma].
    Korting HC; Strasser S; Konz B
    Hautarzt; 1988 Mar; 39(3):170-3. PubMed ID: 3378889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Growth of transplantable Guérin tumor and Morris hepatoma in rats after a single dose of BCG vaccine according to different timetables].
    Nowak HF; Cylwik B; Zimnoch L; Jodczyk KJ; Pregowski W; Duda D; Bernaczyk A
    Patol Pol; 1981; 32(2):173-84. PubMed ID: 7322639
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)].
    Ogura T
    Kekkaku; 1980 Aug; 55(8):359-63. PubMed ID: 6999203
    [No Abstract]   [Full Text] [Related]  

  • 11. The biologic activity of MER-BCG in experimental systems and preliminary clinical studies.
    Mikulski SM; Muggia FM
    Cancer Treat Rev; 1977 Jun; 4(2):103-17. PubMed ID: 329986
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
    Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
    Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of melanoma with intralesional BCG.
    Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
    Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
    [No Abstract]   [Full Text] [Related]  

  • 14. [Possibilities of an immunotherapy of malignant skin tumors with particular consideration of malignant melanomas (author's transl)].
    Schöpf E
    Ther Umsch; 1976 Aug; 33(8):538-42. PubMed ID: 1006610
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer immunotherapy.
    Richman SP; Gutterman JU; Hersh EM
    Can Med Assoc J; 1979 Feb; 120(3):322-4, 329. PubMed ID: 371776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nonspecific immunostimulation and immunochemotherapy of melanomas].
    Israël L
    Rev Prat; 1975 Nov; 25(51):4063-4, 4067-8. PubMed ID: 1209147
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of the complications occurring in BCG vaccine immunotherapy of patients with malignant neoplasms].
    Grigorovich NA; Risina DIa; Nodel'son SE
    Vopr Onkol; 1984; 30(7):102-6. PubMed ID: 6464396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bladder tumor model response to immunotherapy.
    deKernion JB; Ramming KP; Fraser K
    Natl Cancer Inst Monogr; 1978 Dec; (49):333. PubMed ID: 748789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological treatment of sarcoid skin lesions by old tuberculin, blood, and BCG (author's transl)].
    Berdel W; Malin J; Berdel WE
    Dermatol Monatsschr; 1979 Sep; 165(9):642-7. PubMed ID: 527744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 165.